|
Market Closed -
NSE India S.E.
15:23:44 25/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 59.10 INR | +0.05% |
|
-0.42% | -23.93% |
Company Valuation: Alpa Laboratories Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 757.5 | 1,467 | 1,132 | 1,752 | 2,180 | 977.5 |
| Change | - | 93.61% | -22.81% | 54.74% | 24.44% | -55.15% |
| Enterprise Value (EV) 1 | 334.5 | 822.3 | 346.6 | 875.6 | 1,053 | -376.2 |
| Change | - | 145.84% | -57.85% | 152.61% | 20.26% | -135.73% |
| P/E | 10.5x | 10.4x | 9x | 10.4x | 11.2x | 6.51x |
| PBR | 0.7x | 1.2x | 0.84x | 1.15x | 1.27x | 0.52x |
| PEG | - | 0.1x | -0.8x | 0.3x | 0.7x | -0.3x |
| Capitalization / Revenue | 0.78x | 1.19x | 1.22x | 1.61x | 1.94x | 0.92x |
| EV / Revenue | 0.34x | 0.67x | 0.37x | 0.81x | 0.94x | -0.36x |
| EV / EBITDA | 3.87x | 3.83x | 4.28x | 10.2x | 22.4x | -11.4x |
| EV / EBIT | 4.52x | 4.16x | 5.13x | 13.2x | 42.1x | -31.4x |
| EV / FCF | -2.57x | 4.89x | 5.29x | -15.6x | 23.7x | -3.88x |
| FCF Yield | -38.9% | 20.4% | 18.9% | -6.4% | 4.22% | -25.8% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | 3.444 | 6.697 | 5.98 | 7.973 | 9.269 | 7.134 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 975.5 | 1,230 | 929.6 | 1,087 | 1,125 | 1,058 |
| EBITDA 1 | 86.33 | 214.4 | 80.91 | 86.13 | 47.03 | 32.9 |
| EBIT 1 | 74.04 | 197.8 | 67.62 | 66.58 | 25.01 | 11.98 |
| Net income 1 | 72.47 | 140.9 | 125.8 | 167.8 | 195 | 150.1 |
| Net Debt 1 | -423 | -644.3 | -785.4 | -876.1 | -1,127 | -1,354 |
| Reference price 2 | 36.00 | 69.70 | 53.80 | 83.25 | 103.60 | 46.46 |
| Nbr of stocks (in thousands) | 21,041 | 21,041 | 21,041 | 21,041 | 21,041 | 21,041 |
| Announcement Date | 9/6/21 A | 9/3/22 A | 9/5/23 A | 9/4/24 A | 9/4/25 A | 9/7/26 A |
1INR in Million2INR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 12.97M | ||
| 34.18x | 6.41x | 22.23x | 0.92% | 46.37B | ||
| 15.96x | 1.97x | 8.77x | 1.69% | 37.26B | ||
| 28.87x | 4.1x | 17.01x | 0.56% | 12.53B | ||
| 27.25x | 3.31x | 17.13x | 0.93% | 11.8B | ||
| 18.58x | 3.37x | 11.75x | 3.79% | 8.97B | ||
| 9.18x | 2.12x | 5.48x | 4.84% | 7.09B | ||
| 28.95x | 3.78x | 17.59x | 0.16% | 7.01B | ||
| 15.51x | 2.06x | 6.85x | 3.21% | 7.29B | ||
| Average | 22.31x | 3.39x | 13.35x | 2.01% | 15.37B | |
| Weighted average by Cap. | 24.65x | 3.96x | 15.11x | 1.57% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ALPA Stock
- Valuation Alpa Laboratories Limited
Select your edition
All financial news and data tailored to specific country editions
















